Intra-Cellular Therapies Income Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	746,139	646,015	416,024	379,811	747,036	1,135,902	Upgrade
Revenue Growth (YoY)	28.62%	55.28%	9.53%	-49.16%	-34.23%	63.21%	Upgrade
Cost of Revenue	220,044	209,299	228,831	324,094	515,156	708,418	Upgrade
Gross Profit	526,094	436,716	187,193	55,717	231,880	427,484	Upgrade
Selling, General & Admin	71,350	70,040	48,875	46,606	81,867	70,485	Upgrade
Operating Expenses	71,350	70,040	48,875	46,606	81,867	70,485	Upgrade
Operating Income	454,744	366,676	138,318	9,112	150,013	356,998	Upgrade
Interest Expense	-15,914	-15,914	-472.9	-	-17,275	-10,303	Upgrade
Interest & Investment Income	3,573	3,573	5,168	33,572	3,671	2,283	Upgrade
Earnings From Equity Investments	-	-	-728.01	-11,560	-30,677	-1,573	Upgrade
Other Non Operating Income (Expenses)	-1,221	-208.61	1,605	7,798	-3,767	-236,580	Upgrade
EBT Excluding Unusual Items	441,182	354,127	143,890	38,922	101,965	110,827	Upgrade
Gain (Loss) on Sale of Investments	1,503	1,503	108,723	-12,571	13,914	1,451	Upgrade
Other Unusual Items	-	-	-	150,000	-	-	Upgrade
Pretax Income	442,685	355,630	252,613	176,351	115,879	112,277	Upgrade
Income Tax Expense	99,151	86,240	68,847	55,706	31,692	70,333	Upgrade
Earnings From Continuing Operations	343,534	269,390	183,766	120,645	84,187	41,944	Upgrade
Minority Interest in Earnings	-571.26	-881.69	1,572	-959.12	-19,409	-11,379	Upgrade
Net Income	342,963	268,508	185,337	119,686	64,778	30,565	Upgrade
Preferred Dividends & Other Adjustments	-	-	128.16	279.34	4,281	3,222	Upgrade
Net Income to Common	342,963	268,508	185,209	119,407	60,497	27,343	Upgrade
Net Income Growth	61.39%	44.88%	54.85%	84.76%	111.94%	-70.85%	Upgrade
Shares Outstanding (Basic)	295	295	295	295	295	295	Upgrade
Shares Outstanding (Diluted)	295	295	295	295	295	295	Upgrade
Shares Change (YoY)	-0.01%	-	-	-	-	-	Upgrade
EPS (Basic)	1162.68	910.21	627.84	404.78	205.08	92.69	Upgrade
EPS (Diluted)	1162.51	910.04	627.80	404.63	205.02	92.66	Upgrade
EPS Growth	61.38%	44.96%	55.15%	97.36%	121.25%	-71.59%	Upgrade
Free Cash Flow	211,005	196,967	-831,992	-661,741	-400,095	60,310	Upgrade
Free Cash Flow Per Share	715.33	667.70	-2820.37	-2243.23	-1356.28	204.44	Upgrade
Dividend Per Share	-	-	-	-	-	115.830	Upgrade
Dividend Growth	-	-	-	-	-	-70.00%	Upgrade
Gross Margin	70.51%	67.60%	45.00%	14.67%	31.04%	37.63%	Upgrade
Operating Margin	60.95%	56.76%	33.25%	2.40%	20.08%	31.43%	Upgrade
Profit Margin	45.97%	41.56%	44.52%	31.44%	8.10%	2.41%	Upgrade
Free Cash Flow Margin	28.28%	30.49%	-199.99%	-174.23%	-53.56%	5.31%	Upgrade
EBITDA	462,521	374,398	145,469	17,288	159,408	367,129	Upgrade
EBITDA Margin	61.99%	57.95%	34.97%	4.55%	21.34%	32.32%	Upgrade
D&A For EBITDA	7,777	7,722	7,151	8,176	9,395	10,130	Upgrade
EBIT	454,744	366,676	138,318	9,112	150,013	356,998	Upgrade
EBIT Margin	60.95%	56.76%	33.25%	2.40%	20.08%	31.43%	Upgrade
Effective Tax Rate	22.40%	24.25%	27.25%	31.59%	27.35%	62.64%	Upgrade
Revenue as Reported	746,139	646,015	416,024	379,811	747,036	1,135,902	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.